|
gptkbp:instanceOf
|
gptkb:brand
gptkb:drug
|
|
gptkbp:activeIngredient
|
gptkb:chlordiazepoxide
|
|
gptkbp:ATCCode
|
N05BA02
|
|
gptkbp:CASNumber
|
58-25-3
|
|
gptkbp:chemicalFormula
|
C16H14ClN3O
|
|
gptkbp:contraindication
|
gptkb:myasthenia_gravis
severe respiratory insufficiency
sleep apnea syndrome
severe hepatic insufficiency
|
|
gptkbp:controlledSubstanceSchedule
|
Schedule IV (US)
|
|
gptkbp:discoveredBy
|
gptkb:Leo_Sternbach
|
|
gptkbp:drugClass
|
gptkb:benzodiazepine
|
|
gptkbp:eliminationHalfLife
|
5-30 hours
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:firstBenzodiazepineMarketed
|
true
|
|
gptkbp:form
|
gptkb:tablet
capsule
|
|
gptkbp:introducedIn
|
1960
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:Hoffmann-La_Roche
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:overdoseSymptoms
|
coma
hypotension
respiratory depression
|
|
gptkbp:pregnancyCategory
|
D (US)
|
|
gptkbp:riskFactor
|
abuse potential
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
confusion
fatigue
drowsiness
ataxia
dependence
|
|
gptkbp:synonym
|
chlordiazepoxide hydrochloride
|
|
gptkbp:usedFor
|
anxiety disorders
alcohol withdrawal
preoperative sedation
|
|
gptkbp:bfsParent
|
gptkb:Chlordiazepoxide
gptkb:Leo_Sternbach
|
|
gptkbp:bfsLayer
|
7
|
|
http://www.w3.org/2000/01/rdf-schema#label
|
Librium
|